v3.26.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net increase (decrease) in net assets from operations $ 1,943,207 $ (9,125,901)
Adjustments to reconcile net increase (decrease) in net assets to net cash (used in) provided by operating activities:    
Investments in portfolio companies (12,027,924) (3,309,755)
Proceeds from sale of portfolio investments 2,278,519 955,357
Proceeds from loan repayments 2,016,250 16,831,276
Net realized (gain) loss on sales and dispositions of portfolio investments (13,635) 2,001,997
Change in unrealized appreciation/depreciation on investments (45,157) 11,902,301
Deferred income tax benefit 0 (114,728)
Amortization 18,750 18,750
Original issue discount amortization (4,800) (37,804)
Non-cash conversion of debenture interest (458,812) (1,841,203)
Non-cash conversion of loan modification fee 0 (15,000)
Change in interest receivable allowance 0 25,337
Changes in operating assets and liabilities:    
(Increase) decrease in interest receivable (73,348) 148,456
Increase in other assets (96,839) (17,073)
Increase in prepaid income taxes (25,814) (14,324)
Increase (decrease) in accounts payable and accrued expenses 14,429 (27,592)
Increase (decrease) in due to investment adviser 36,278 (1,655,621)
Decrease in capital gains incentive fees payable 0 (1,565,000)
Increase (decrease) in deferred revenue 36,489 (150,368)
Total adjustments (8,345,614) 23,135,006
Net cash (used in) provided by operating activities (6,402,407) 14,009,105
Cash flows from financing activities:    
Proceeds from Lines of Credit 12,800,000 1,500,000
Repayment of line of credit (7,800,000) (2,100,000)
Payment of cash dividend (2,583,621) (4,753,163)
Net cash provided by (used in) financing activities 2,416,379 (5,353,163)
Net (decrease) increase in cash and cash equivalents (3,986,028) 8,655,942
Cash and cash equivalents:    
Beginning of period 4,208,948 834,805
End of period $ 222,920 $ 9,490,747